Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats

Journal of Veterinary Cardiology

Volumn 11, Issue SUPPL. 1, 2009, Pages

  Fox, Philip R ^a   Oyama, Mark A ^b   Reynolds, Caryn ^b   Rush, John E ^c   DeFrancesco, Terri C ^d   Keene, Bruce W ^d   Atkins, Clark E ^d   MacDonald, Kristin A ^e   Schober, Karsten E ^f   Bonagura, John D ^f   Stepien, Rebecca L ^g   Kellihan, Heidi B ^g   Nguyenba, Thaibinh P ^h   Lehmkuhl, Linda B ^h   Lefbom, Bonnie K ⁱ   Moise, N Sydney ^j   Hogan, Daniel F ^k  

^a ANIMAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TUFTS UNIVERSITY   (United States)

^d NORTH CAROLINA STATE UNIVERSITY   (United States)

^e MedVet Associates Inc ^*  (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

^h MedVet   (United States)

ⁱ Chesapeake Veterinary Cardiology Associates   (United States)

^j Department of Obstetrics Gynecology   (United States)

^k PURDUE UNIVERSITY   (United States)

more..

Author keywords

Dyspnea; Feline; Heart failure; NT proBNP; Respiratory disease

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; NITROGEN; THYROXINE; UREA;

ARTICLE; CARDIOMEGALY; CAT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART SIZE; KIDNEY FAILURE; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; RESPIRATORY TRACT DISEASE; ROC CURVE; SENSITIVITY AND SPECIFICITY; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CAT DISEASES; CATS; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; FEMALE; HEART FAILURE; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RESPIRATION DISORDERS; ROC CURVE;

FELIDAE;

EID: 67349111689     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvc.2008.12.001     Document Type: Article

References (57)

1. Isaac D.L. Biomarkers in heart failure management. Curr Opin Cardiol 23 (2008) 127-133
2. Braunwald E. Biomarkers in heart failure. N Engl J Med 358 (2008) 2148-2159
3. Fonarow G.C., Peacock W.F., Phillips C.O., Givertz M.M., and Lopatin M. ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 1943-1950
4. Doust J.A., Glasziou P.P., Pietzak E., and Dobson A.J. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164 (2004) 1978-1984
5. Felker G.M., Peterson J.W., and Mark D.B. Natriuretic peptides in the diagnosis and management of heart failure. Can Med Assoc J 175 (2006) 611-617
6. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-327
7. Wilkins M.R., Redondo J., and Brown L.A. The natriuretic-peptide family. Lancet 349 (1997) 1307-1310
8. Nakagawa O., Ogawa Y., Itoh H., Suga S., Komatsu Y., Kishimoto I., Nishino K., Yoshimasa T., and Nakao K. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 3 (1995) 1280-1287
9. Goetze J.P., Rehfeld J.F., Videbaek R., Friis-Hansen L., and Kastrup J. B-type natriuretic peptide and its precursor in cardiac venous blood from failing hearts. Eur J Heart Fail 7 (2005) 69-74
10. Hunt P.J., Richards A.M., Nicholls M.G., Yandle T.G., and Doughty R.N. Espiner EA Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 47 (1997) 287-296
11. Worster A., Balion C.M., Hill S.A., Santaguida P., Isi Ismaila A., McKelvie R., Reichert S.M., McQueen M.J., Booker L., and Raina P.S. Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review. Clin Biochem 41 (2008) 250-259
12. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., Baggish A.L., Chen A.A., Krauser D.G., Tung R., Cameron R., Nagurney J.T., Chae C.U., Lloyd-Jones D.M., Brown D.F., Foran-Melanson S., Sluss P.M., Lee-Lewandrowski E., and Lewandrowski K.B. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
13. Moe G.W., Howlett J., Januzzi J.L., Zowall H., and Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study Investigators. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation 115 (2007) 3103-3110
14. MacDonald K.A., Kittleson M.D., Munro C., and Kass P. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. J Vet Intern Med 17 (2003) 172-177
15. Häggström J., Hansson K., Kvart C., Pedersen H.D., Vuolteenaho O., and Olsson K. Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease. J Vet Cardiol 2 (2000) 7-16
16. Oyama M.A., Fox P.R., Rush J.E., Rozanski E.A., and Lesser M. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc 232 (2008) 1496-1503
17. DeFrancesco T.C., Rush J.E., Rozanski E.A., Hansen B.D., Keene B.W., Moore D.T., and Atkins C.E. Prospective clinical evaluation of an ELISA B-type natriuretic peptide assay in the diagnosis of congestive heart failure in dogs presenting with cough or dyspnea. J Vet Intern Med 21 (2007) 243-250
18. Fine D.M., Declue A.E., and Reinero C.R. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease. J Am Vet Med Assoc 232 (2008) 1674-1679
19. Mandell D.C. Respiratory distress in cats. In: King L.G. (Ed). Respiratory disease in dogs and cats (2004), WB Saunders, St Louis 12-17
20. Schober K.E., Maerz I., Ludewig E., and Stern J.A. Diagnostic accuracy of electrocardiography and thoracic radiography in the assessment of left atrial size in cats: comparison with transthoracic 2-dimensional echocardiography. J Vet Intern Med 21 (2007) 709-718
21. Rush J.E., Freeman L.M., Fenollosa N.K., and Brown D.J. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999). J Am Vet Med Assoc 220 (2002) 202-207
22. Fox P.R., Liu S.K., and Maron B.J. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease. Circulation 92 (1995) 2645-2651
23. Hori Y., Yamano S., Iwanaga K., Kano T., Tanabe M., Uechi M., Kanai K., Nakao R., Hoshi F., and Higuchi S. Evaluation of plasma C-terminal atrial natriuretic peptide in healthy cats and cats with heart disease. J Vet Intern Med 22 (2008) 135-139
24. MacLean H.N., Abbott J.A., Ward D.L., Huckle W.R., Sisson D.D., and Pyle R.L. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. J Vet Intern Med 20 (2006) 284-289
25. Biondo A.W., Ehrhart E.J., Sisson D.D., Bulmer B.J., De Morais H.S., and Solter P.F. Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy. Vet Pathol 40 (2003) 501-506
26. Connolly D.J., Soares Magalhaes R.J., Syme H.M., Boswood A., Luis Fuentes V., Chu L., and Metcalf M. Circulating natriuretic peptides in cats with heart disease. J Vet Intern Med 22 (2008) 96-105
27. MacDonald K.A., Kittleson M.E., Larson R.F., Kass P., Klose T., and Wisner E.R. The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure. J Vet Intern Med 20 (2006) 1093-1105
28. Thomas W.P., Gaber C.E., Jacobs G.J., Kaplan P.M., Lombard C.W., Moise N.S., and Moses B.L. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 7 (1993) 247-252
29. Schober K.E., Fuentes V.L., and Bonagura J.D. Comparison between invasive hemodynamic measurements and noninvasive assessment of left ventricular diastolic function by use of Doppler echocardiography in healthy anesthetized cats. Am J Vet Res 64 (2003) 93-103
30. Oyama M.A., Sisson D.D., Bulmer B.J., and Constable P.D. Echocardiographic estimation of mean left atrial pressure in a canine model of acute mitral valve insufficiency. J Vet Intern Med 18 (2004) 667-672
31. Litster A.L., and Buchanan J.W. Vertebral scale system to measure heart size in radiographs of cats. J Am Vet Med Assoc 216 (2000) 210-214
32. Fox P.R. Endomyocardial fibrosis and restrictive cardiomyopathy: pathologic and clinical features. J Vet Cardiol 6 (2004) 25-31
33. Fox P.R. Feline cardiomyopathies. In: Fox P.R., Sisson D.D., and Moise N.S. (Eds). Textbook of canine and feline cardiology principals and practice. 2nd ed (1999), WB Saunders, Philadelphia 621-678
34. Boswood A., Dukes-McEwan J., Loureiro J., James R.A., Martin M., Stafford-Johnson M., Smith P., Little C., and Attree S. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Animal Pract 49 (2008) 26-32
35. Brito D., Matias J.S., Sargento L., Cabral M.J., and Madeira H.C. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy hypertrophic cardiomyopathy. Rev Port Cardiol 23 (2004) 1557-1582
36. Kaski J.P., Tomé-Esteban M.T., Mead-Regan S., Pantazis A., Marek J., Deanfield J.E., McKenna W.J., and Elliott P.M. B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy. Heart 94 (2008) 1307-1311
37. Ceyhan C., Unal S., Yenisey C., Tekten T., and Ceyhan F.B. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients. Int J Cardiovasc Imaging 24 (2008) 253-259
38. Tschöpe C., Kasner M., Westermann D., Gaub R., Poller W.C., and Schultheiss H.P. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 26 (2005) 2277-2284
39. Panou F.K., Kotseroglou V.K., Lakoumentas J.A., Chrysanthopoulou S.A., Armeniakos J.A., Stratigou T., Veve H., and Zacharoulis A.A. Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. Hellenic J Cardiol 47 (2006) 344-351
40. Arteaga E., Araujo A.Q., Buck P., Ianni B.M., Rabello R., and Mady C. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy. Am Heart J 150 (2005) 1228-1232
41. Mady C., Fernandes F., Arteaga E., Ramires F.J., Buck Pde C., Salemi V.M., Ianni B.M., Nastari L., and Dias R.R. Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies. Arq Bras Cardiol 911 (2008) 46-54
42. Takemura G., Takatsu Y., Doyama K., Itoh H., Saito Y., Koshiji M., Ando F., Fujiwara T., Nakao K., and Fujiwara H. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol 31 (1998) 754-765
43. Guglin M., Hourani R., and Pitta S. Factors determining extreme brain natriuretic peptide elevation. Congest Heart Fail 13 (2007) 136-141
44. Luchner A., Burnett Jr. J.C., Jougasaki M., Hense H.W., Heid I.M., Muders F., Riegger G.A., and Schunkert H. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 18 (2000) 1121-1128
45. Anwaruddin S., Lloyd-Jones D.M., Baggish A., Chen A., Krauser D., Tung R., Chae C., and Januzzi Jr. J.L. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47 (2006) 91-97
46. Tagore R., Ling L.H., Yang H., Daw H.Y., Chan Y.H., and Sethi S.K. Natriuretic peptides in chronic kidney disease. Clin J Am Soc Nephrol 53 (2007) 1511-1519
47. deFilippide C.R., Seliger S.L., Maynard S., and Christenson R.H. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 53 (2007) 1511-1519
48. Bruch C., Fischer C., Sindermann J., Stypmann J., Breithardt G., and Gradaus R. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol 102 (2008) 469-474
49. Missov E., Calzolari C., and Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 96 (1997) 2953-2958
50. Horwich T.B., Patel J., MacLellan W.R., and Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
51. Connolly D.J., Cannata J., Boswood A., Archer J., Groves E.A., and Neiger R. Cardiac troponin I in cats with hypertrophic cardiomyopathy. J Feline Med Surg 5 (2003) 209-216
52. Ricchiuti V., Sharkey S.W., Murakami M.M., Voss E.M., and Apple F.S. Cardiac troponin I and T alterations in dog hearts with myocardial infarction: correlation with infarct size. Am J Clin Pathol 110 (1998) 241-247
53. Ammann P., Fehr T., Minder E.I., Gunter C., and Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 27 (2001) 965-969
54. Burness C.E., Beacock D., and Channer K.S. Pitfalls and problems of relying on serum troponin. Q J Med 98 (2005) 365-371
55. Porciello F., Rishniw M., Herndon W., Birettoni F., Antognoni M., and Simpson K. Cardiac troponin I is elevated in dogs and cats with azotaemia renal failure and in dogs with non-cardiac systemic disease. Aust Vet J 86 (2008) 390-394
56. Schober K.E., Cornand C., Kirbach B., Aupperle H., and Oechtering G. Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc 221 (2002) 381-388
57. Herndon W.E., Rishniw M., Schrope D., Sammarco C.D., Boddy K.N., and Sleeper M.M. Assessment of plasma cardiac troponin I concentration as a means to differentiate cardiac and noncardiac causes of dyspnea in cats. J Am Vet Med Assoc 232 (2008) 1261-1264